Douglas J. Hughes

Douglas J. Hughes is a declared insider at 2 companies (senior executive); the most frequent names are Immunovant, Inc. and Eargo, Inc. The record holds 10 filings, for trades running from 27 August 2021 to 7 April 2026.

Both buying and selling appear: 1 purchase worth €128k, against 2 sales worth €408k. Sales outweigh purchases by €280k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 7 share grants.

The record was last updated on 9 April 2026 with a share grant in Immunovant, Inc. The latest purchase dates back some time: it was published 1,897 days ago, on 30 August 2021. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.